Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum, formoteroli fumaras dihydricus - pulver zur inhalation - budesonidum 200 µg, formoteroli fumaras dihydricus 6 µg, lactosum monohydricum, ad pulverem pro dosi. - antiasthmatikum, copd - synthetika

Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum, formoteroli fumaras dihydricus - pulver zur inhalation - budesonidum 400 µg, formoteroli fumaras dihydricus 12 µg, lactosum monohydricum, ad pulverem pro dosi, doses pro vase 60. - antiasthmatikum, copd - synthetika

Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum, formoteroli fumaras dihydricus - dosieraerosol - budesonidum 100 µg, formoteroli fumaras dihydricus 6 µg, povidonum k 25, macrogolum 1000, apafluranum, ad aerosolum pro dosi corresp. 74.6 mg. doses pro vase 120. - asthma bronchiale, copd - synthetika

Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum, formoteroli fumaras dihydricus - dosieraerosol - budesonidum 200 µg, formoteroli fumaras dihydricus 6 µg, povidonum k 25, macrogolum 1000, apafluranum, ad aerosolum pro dosi corresp. 74.6 mg. doses pro vase 120. - asthma bronchiale, copd - synthetika

Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - ticagrelorum - filmtabletten - ticagrelorum 90 mg, mannitolum, calcii hydrogenophosphas dihydricus, carboxymethylamylum natricum a, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, e 171, talcum, macrogolum 400, e 172 (flavum), pro compresso obducto corresp. natrium 0.38 mg. - thrombozytenaggregationshemmung in kombination mit acetylsalicylsäure - synthetika

Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - ticagrelorum - filmtabletten - ticagrelorum 60 mg, mannitolum, calcii hydrogenophosphas dihydricus, carboxymethylamylum natricum a, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, e 171, macrogolum 400, e 172 (nigrum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.25 mg. - thrombozytenaggregationshemmung in kombination mit acetylsalicylsäure - synthetika

Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - ticagrelorum - schmelztabletten - ticagrelorum 90 mg, mannitolum, cellulosum microcristallinum, crospovidonum, xylitolum, calcii hydrogenophosphas, natrii stearylis fumaras, hydroxypropylcellulosum, silica colloidalis anhydrica, pro compresso corresp. natrium 0.53 mg. - thrombozytenaggregationshemmung in kombination mit acetylsalicylsäure - synthetika

Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - benralizumabum - lnjektionslösung - benralizumabum 30 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - schweres eosinophiles asthma - biotechnologika

Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - exenatidum - depot-lnjektionssuspension in einem autoinjektor - exenatidum 2 mg, saccharum, poly(lactidum-co-glycolidum) 50/50 (0.40 - 0.49 dl/g), triglycerida media, ad suspensionem pro dosi. - antidiabetikum - synthetika

Suíça - alemão - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - acalabrutinibum - hartkapseln - acalabrutinibum 100 mg, cellulosum microcristallinum silicificatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium max. 0.25 mg, magnesii stearas, kapselhülle: gelatina, e 172 (flavum), e 132, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - chronisch lymphatische leukämie (cll) - synthetika